Monoethanolamine

Monoethanolamine

SCHEMBL27966440

CCCCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)OCCCCC(=O)O.NCCO

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ LPAR3 Q9UBY5 9/20 0.70
▸ LPAR1 Q92633 8/20 0.70
▸ LPAR2 Q9HBW0 3/20 0.53
▸ LPAR5 Q9H1C0 3/20 0.51
▸ TLR2 O60603 3/20 0.50
▸ PLA2G2C Q5R387 1/20 0.49
▸ RECQL P46063 1/20 0.48
▸ ENPP2 Q13822 5/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ LPAR6 P43657 2/20 0.44
▸ LPAR4 Q99677 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Monoethanolamine SCHEMBL27966443 1.00 LPAR3 (0.70) LPAR3LPAR1LPAR2LPAR5TLR2
Monoethanolamine SCHEMBL27966569 1.00 LPAR3 (0.70) LPAR3LPAR1LPAR2LPAR5TLR2
Monoethanolamine SCHEMBL27966570 1.00 LPAR3 (0.70) LPAR3LPAR1LPAR2LPAR5TLR2
Monoethanolamine SCHEMBL27966448 0.95 LPAR3 (0.61) LPAR3LPAR1LPAR2LPAR5TLR2
SCHEMBL28150233 0.93 LPAR3 (0.82) LPAR3LPAR1LPAR2LPAR5RECQL
SCHEMBL2232554 0.93 LPAR3 (0.82) LPAR3LPAR1LPAR2LPAR5RECQL
SCHEMBL12345721 0.93 LPAR3 (0.82) LPAR3LPAR1LPAR2LPAR5RECQL
Monoethanolamine SCHEMBL27411197 0.92 LPAR3 (0.84) LPAR3LPAR1LPAR2LPAR5TLR2
Monoethanolamine SCHEMBL27549117 0.92 LPAR3 (0.84) LPAR3LPAR1LPAR2LPAR5TLR2
Monoethanolamine SCHEMBL27635540 0.91 LPAR3 (0.81) LPAR3LPAR1LPAR2LPAR5TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103874485-A Formulations and dosage forms of oxidized phospholipids VASCULAR BIOGENICS LTD 2014-06-18 — — CN disclosed
Send feedback